Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes

Abstract

The inflammatory response is involved in the pathogenesis of the most common types of heart disease. Sanguinarine (SAN) has various pharmacological properties such as anti-inflammatory, antioxidant, antibacterial, antitumor, and immune-enhancing properties. However, few studies have investigated the effects of SAN on lipopolysaccharide (LPS)-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes. Therefore, in this study, H9c2 cells were co-treated with SAN and LPS, and the mRNA levels of pro-inflammation markers and the apoptosis rate were measured to clarify the effect of SAN on cardiac inflammation. The underlying mechanism was further investigated by detecting the activation of Toll-like receptor (TLR)4/nuclear factor-κB (NF-κB) signaling pathways. As a result, increased mRNA expression of interleukin (IL)-1β, IL-6, and TNFα induced by LPS was attenuated after SAN treatment; LPS-induced apoptosis of H9c2 cardiomyocytes and cleaved-caspase 8, 9, 3 were all significantly reduced by SAN. Further experiments showed that the beneficial effect of SAN on blocking the inflammation and apoptosis of H9c2 cardiomyocytes induced by LPS was associated with suppression of the TLR4/NF-κB signaling pathway. It was suggested that SAN suppressed the LPS-induced inflammation and apoptosis of H9c2 cardiomyocytes, which may be mediated by inhibition of the TLR4/NF-κB signaling pathway. Thus, SAN may be a feasible therapy to treat sepsis patients with cardiac dysfunction.

Keywords

lipopolysaccharides / sanguinarine / inflammation / H9c2 cardiac cells / apoptosis

References

[1] AngusDC, PereiraCA, SilvaE. Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets, 2006, 6(2): 207-212

[2] HotchkissRS, KarlIE. The pathophysiology and treatment of sepsis. N Engl J Med, 2003, 348(2): 138-150

[3] MerxMW, WeberC. Sepsis and the heart. Circulation, 2007, 116(7): 793-802

[4] LuYC, YehWC, OhashiPS. LPS/TLR4 signal transduction pathway. Cytokine, 2008, 42(2): 145-151

[5] TienYC, LinJY, LaiCH, et al.. Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells. J Ethnopharmacol, 2010, 130(3): 505-513

[6] NemotoS, VallejoJG, KnuefermannP, et al.. Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol, 2002, 282(6): H2316-H2323

[7] ZhouH, QianJ, LiC, et al.. Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Cardiovasc Res, 2011, 89(1): 109-118

[8] DongXZ, ZhangM, WangK, et al.. Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells. Biomed Res Int, 2013, 2013: 517698

[9] ChaturvediMM, KumarA, DarnayBG, et al.. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem, 1997, 272(48): 30129-30134

[10] DengW, FangY, LiuY, et al.. Sanguinarine protects against pressure overload-induced cardiac remodeling via inhibition of nuclear factor-?B activation. Mol Med Rep, 2014, 10(1): 211-216

[11] HerbertJM, AugereauJM, GleyeJ, et al.. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun, 1990, 172(3): 993-999

[12] HeschelerJ, MeyerR, PlantS, et al.. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res, 1991, 69(6): 1476-1486

[13] WatkinsSJ, BorthwickGM, ArthurHM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim, 2011, 47(2): 125-131

[14] ChenTH, WoHT, WuCC, et al.. Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis. Immunopharmacol Immunotoxicol, 2012, 34(3): 484-490

[15] KapadiaS, LeeJ, Torre-AmioneG. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest, 1995, 96(2): 1042-1052

[16] BozkurtB, KribbsSB, ClubbF J, et al.. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 1998, 97(14): 1382-1391

[17] Van der HeidenK, CuhlmannS, et al.. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond), 2010, 118(10): 593-605

[18] GhoshS, BaltimoreD. Activation in vitro of NFkappa B by phosphorylation of its inhibitor I kappa B. Nature, 1990, 344(6267): 678-682

[19] LiuCJ, LoJF, KuoCH, et al.. Akt mediates 17betaestradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necresis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway. J Cell Mol Med, 2009, 13(9B): 3655-3667

[20] WenckerD, ChandraM, NguyenK, et al.. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest, 2003, 111(10): 1497-1504

[21] Qipshidze-KelmN, PiellKM, SolingerJC, et al.. Cotreatment with conjugated linoleic acid and nitrite protects against myocardial infarction. Redox Biol, 2013, 2: 1-7